SCHEMBL10690911

SCHEMBL10690911

CONc1cc(OC)c(C(=O)NC2CN3CCC2CC3)cc1Cl

nearest known ligand 0.74

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 4/20 0.74
HTR3E A5X5Y0 2/20 0.74
HTR3B O95264 2/20 0.74
HTR3D Q70Z44 2/20 0.74
HTR3C Q8WXA8 2/20 0.74
HTR5A P47898 1/20 0.74
MEN1 O00255 1/20 0.74
CYP2D6 P10635 1/20 0.74
CYP2C9 P11712 1/20 0.74
CYP2C19 P33261 1/20 0.74
KMT2A Q03164 1/20 0.74
MAPK1 P28482 1/20 0.71
NPSR1 Q6W5P4 1/20 0.57
DRD4 P21917 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mezacopride SCHEMBL678003 0.90 HTR3A (0.75) HTR3AHTR3EHTR3BHTR3DHTR3C
Mezacopride SCHEMBL1802144 0.90 HTR3A (0.75) HTR3AHTR3EHTR3BHTR3DHTR3C
Mezacopride SCHEMBL9601284 0.90 HTR3A (0.75) HTR3AHTR3EHTR3BHTR3DHTR3C
Mezacopride SCHEMBL7278137 0.90 HTR3A (0.75) HTR3AHTR3EHTR3BHTR3DHTR3C
Mezacopride SCHEMBL10517254 0.89 MAPK1 (0.74) HTR3AHTR3EHTR3BHTR3DHTR3C
Hydrochloric Acid SCHEMBL7278968 0.88 MAPK1 (0.71) HTR3AHTR3EHTR3BHTR3DHTR3C
(R)Zacopride SCHEMBL5387843 0.85 HTR3A (1.00) HTR3AHTR3EHTR3BHTR3DHTR3C
Zacopride SCHEMBL16003 0.85 HTR3A (1.00) HTR3AHTR3EHTR3BHTR3DHTR3C
Zacopride SCHEMBL29567897 0.85 HTR3A (1.00) HTR3AHTR3EHTR3BHTR3DHTR3C
Zacopride SCHEMBL5373467 0.85 HTR3A (1.00) HTR3AHTR3EHTR3BHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4717563-A 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs A. H. ROBINS COMPANY, INC. (US) 1988-01-05 US disclosed